MP-0250

DB17218Investigational

MP-0250: Overview.

Mechanism: Pharmacologically active on Vascular endothelial growth factor A, long form and Hepatocyte growth factor
Curator reviewed
Also known as: Designed ankyrin repeat protein (MP0250) · VEGF/HGF-targeting darpin MP0250
Code names: MP-0250

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with MP-0250, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.